Article · 23 Apr 2026
Research articlePublished 2013
The effects of lamivudine and recombinant hepatitis B vaccine on chronic carriers of hepatitis B
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The purpose of this study was to determine the effects of lamivudine and recombinant hepatitis B vaccine on chronic hepatitis B carriers. Studies has been shown that in animal models chronic Hepatitis B Vaccination can enhance immune response. Furthermore, treatment with lamivudine has resulting contributes to the maintenance of cellular immune responses than hepatitis antigen B. In this study, a group of eligible patients were divided into three groups. Lamivudine therapy and Vaccination were done in groups 1. In groups 2 lamivudine were used alone. In addition, The third group were used as control. The Fisher exact test was used for data analysis and differences among treatment in this study. The results showed that the only significant difference in the HBs Ag sreoconversion rates were observed between groups 1and control groups at the end of the fifteenth month. The present investigation suggested that the adjuvant therapy with hepatitis B vaccine together with lamivudine in chronic carriers of hepatitis B may lead to the eradication of viral infection in these patients
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in European Journal of Experimental Biology.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalEuropean Journal of Experimental Biology
- SubjectBiology
- BylineArticles whose byline prints “Amir Ezzati Kaklar”
- BylineArticles whose byline prints “Parviz Vahdani”
- BylineArticles whose byline prints “Sara Taravati”